234
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

In silico analysis reveals hypoxia-induced miR-210-3p specifically targets SARS-CoV-2 RNA

, ORCID Icon, , &
Pages 12305-12327 | Received 22 Aug 2022, Accepted 01 Jan 2023, Published online: 08 Feb 2023
 

Abstract

Human coronaviruses (HCoVs) until the emergence of SARS in 2003 were associated with mild cold and upper respiratory tract infections. The ongoing pandemic caused by SARS-CoV-2 has enhanced the potential for infection and transmission as compared to other known members of this family. MicroRNAs (miRNA) are 21-25 nucleotides long non-coding RNA that bind to 3' UTR of genes and regulate almost every aspect of cellular function. Several human miRNAs have been known to target viral genomes, mostly to downregulate their expression and sometimes to upregulate also. In some cases, host miRNAs could be sequestered by the viral genome to create a condition for favourable virus existence. The ongoing SARS CoV-2 pandemic is unique based on its transmissibility and severity and we hypothesised that there could be a unique mechanism for its pathogenesis. In this study, we exploited in silico approach to identify human respiratory system-specific miRNAs targeting the viral genome of three highly pathogenic HCoVs (SARS-CoV-2 Wuhan strain, SARS-CoV, and MERS-CoV) and three low pathogenic HCoVs (OC43, NL63, and HKU1). We identified ten common microRNAs that target all HCoVs studied here. In addition, we identified unique miRNAs which targeted specifically one particular HCoV. miR-210-3p was the single unique lung-specific miRNA, which was found to target the NSP3, NSP4, and NSP13 genes of SARS-CoV-2. Further miR-210-NSP3, miR-210-NSP4, and miR-210-NSP13 SARS-CoV-2 duplexes were docked with the hAGO2 protein (PDB ID 4F3T) which showed Z-score values of −1.9, −1.7, and −1.6, respectively. The role of miR-210-3p as master hypoxia regulator and inflammation regulation may be important for SARS-CoV-2 pathogenesis. Overall, this analysis advocates that miR-210-3p be investigated experimentally in SARS-CoV-2 infection.

Communicated by Ramaswamy H. Sarma

Author contribution

Mirza Sarwar Baig- Conceived and designed research, employed following software and servers in this study-miRDB, Tarbase, miRTarbase, miRTargetLink, miRPathDB, miRSel, STRING DB, DAVID 6.8, IntaRNA, RNAstructureWeb server, RNACOMPOSER, 3dRNA version 2.0 webserver, HADDOCK2.4 biomolecular docking webserver, miR2Disease, PolymiRTS database; analyzed the data, and wrote the manuscript. Deepanshu- Performed MD simulation. Prem Prakash—Performed MD simulation and analysis. Pravej Alam- Performed STarMir analysis for RNA accessibility. Anuja Krishnan- Conceptualised, designed experiments, supervised, analyzed and finalized the manuscript.

Additional information

Funding

The research is supported by the Indian Council of Medical Research (ICMR), New Delhi (VIR/Fellowship/40/2019/ECD-1) to whom M.S.B duly acknowledges. AK acknowledges funding from Department of Biotechnology, (BT/PR40963/COT/142/12/2020) and CCRUM (F.No.3-60/2019-CCRUM/Tech). PP is supported by Science and Engineering Research Board, Department of Science and Technology (ECR/2017/000235 and EEQ/2020/000299), Indian Council of Medical Research (ICMR) (P-12)ITR/Adhoc/18/2020), Department of Biotechnology, (BT/RLF/Re-Entry/24/2015) and the University Grants Commission, Faculty Recharge Programme No.F.4-5(67-FRP) (Cycle-IV)/2017(BSR).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.